Sverre Lehmanns bilde

Sverre Lehmann

Førsteamanuensis, Associate professor, MD, PhD
  • E-postsverre.lehmann@uib.no
  • Telefon+47 971 97 288
  • Besøksadresse
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postadresse
    Postboks 7804
    5020 Bergen

Clinical and epidemiological lung research.

Fields of particular interest: Obstructive lung disease (asthma and COPD), sleep related respiratory disorders, respiratory failure. 


Vitenskapelig artikkel
  • Vis forfatter(e) (2024). Lower airway microbiota in COPD and healthy controls. Thorax.
  • Vis forfatter(e) (2023). Prevalence and management of severe asthma in the Nordic countries: findings from the NORDSTAR cohort. European Respiratory Journal Open Research (ERJ Open Research).
  • Vis forfatter(e) (2023). Prevalence and impact of exercise-induced laryngeal obstruction in asthma: a study protocol for a cross-sectional and longitudinal study. BMJ Open. 8 sider.
  • Vis forfatter(e) (2023). Impact of Inititing Biologics in Patients With Severe Asthma on Long-term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry. Journal of Allergy and Clinical Immunology: In Practice. 2732-2747.
  • Vis forfatter(e) (2023). General and orofacial symptoms associated with acute and long COVID in 80- and 90-year-old Swedish COVID-19 survivors. Journal of Dentistry.
  • Vis forfatter(e) (2023). Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both. Allergy. European Journal of Allergy and Clinical Immunology. 1934-1948.
  • Vis forfatter(e) (2022). The lower airways microbiota and antimicrobial peptides indicate dysbiosis in sarcoidosis. Microbiome. 11 sider.
  • Vis forfatter(e) (2022). The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease . PLOS ONE.
  • Vis forfatter(e) (2022). Clinical information predicting severe obstructive sleep apnea: A cross-sectional study of patients waiting for sleep diagnostics. Respiratory Medicine.
  • Vis forfatter(e) (2022). Characterization of patients in the International Severe Asthma Registry with high steroid exposure who did or did not initiate biologic therapy. Journal of Asthma and Allergy. 1491-1510.
  • Vis forfatter(e) (2022). Characteristics of hypertension and arterial stiffness in obstructive sleep apnea: A Scandinavian experience from a prospective study of 6408 normotensive and hypertensive patients. The Journal of Clinical Hypertension. 385-394.
  • Vis forfatter(e) (2022). Association of Excessive Sleepiness, Pathological Fatigue, Depression, and Anxiety With Different Severity Levels of Obstructive Sleep Apnea. Frontiers in Psychology. 1-8.
  • Vis forfatter(e) (2021). Partner perceptions are associated with objective sensor-measured adherence to oral appliance therapy in obstructive sleep apnea. Journal of Sleep Research.
  • Vis forfatter(e) (2021). Inducible laryngeal obstruction in asthma. European Respiratory Journal.
  • Vis forfatter(e) (2021). Effect of Continuous Positive Airway Pressure on Symptoms and Prevalence of Insomnia in Patients With Obstructive Sleep Apnea: A Longitudinal Study. Frontiers in Psychology. 10 sider.
  • Vis forfatter(e) (2020). NORDSTAR: paving the way for a new era in asthma research. European Respiratory Journal. 7 sider.
  • Vis forfatter(e) (2020). Effect of continuous positive airway pressure on symptoms of anxiety and depression in patients with obstructive sleep apnea. Sleep and Breathing. 1-7.
  • Vis forfatter(e) (2020). Complications and discomfort after research bronchoscopy in the MicroCOPD study. BMJ Open Respiratory Research.
  • Vis forfatter(e) (2020). Acoustic pharyngometry - A new method to facilitate oral appliance therapy. Journal of Oral Rehabilitation. 1-13.
  • Vis forfatter(e) (2019). Motivation and response rates in bronchoscopy studies. Multidisciplinary Respiratory Medicine. 1-9.
  • Vis forfatter(e) (2019). Health-related quality of life as predictor for mortality in patients treated with long-term mechanical ventilation. BMC Pulmonary Medicine. 1-12.
  • Vis forfatter(e) (2019). A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD: The DuoSleep study. The International Journal of Chronic Obstructive Pulmonary Disease. 199-210.
  • Vis forfatter(e) (2018). Sammenhengen mellom ulike somatiske sykdommer og alvorlighetsgraden av obstruktiv søvnapné. PLOS ONE. 1-12.
  • Vis forfatter(e) (2018). Prevalence of parasomnias in patients with obstructive sleep apnea. A registry-based cross-sectional study. Frontiers in Psychology. 1-7.
  • Vis forfatter(e) (2018). No effect of a self-help book for insomnia in patients with obstructive sleep apnea and comorbid chronic insomnia – a randomized controlled trial. Frontiers in Psychology. 2413.
  • Vis forfatter(e) (2018). Increased severity of obstructive sleep apnea is associated with less anxiety and depression. Journal of Sleep Research.
  • Vis forfatter(e) (2018). Akustisk pharyngometri for bedre resultat av behandling med søvnapnéskinner. Den norske tannlegeforenings tidende. 264-267.
  • Vis forfatter(e) (2017). Reliability of an adherence monitoring sensor embedded in an oral appliance used for treatment of obstructive sleep apnea. Journal of Oral Rehabilitation. 110-115.
  • Vis forfatter(e) (2017). Protected sampling is preferable in bronchoscopic studies of the airway microbiome. European Respiratory Journal Open Research (ERJ Open Research).
  • Vis forfatter(e) (2017). Oral appliance treatment outcome can be predicted by continuous positive airway pressure in moderate to severe obstructive sleep apnea. Sleep and Breathing. 1-8.
  • Vis forfatter(e) (2017). Lungefunksjon som risikofaktor for osteoporose og hoftebrudd. Best Practice.
  • Vis forfatter(e) (2017). Factors associated with change in health-related quality of life among individuals treated with long-term mechanical ventilation, a 6-year follow-up study. Journal of Advanced Nursing. 651-665.
  • Vis forfatter(e) (2017). A pilot study of hot-wire, ultrasonic and wedge-bellows spirometer inter- and intra-variability. BMC Research Notes.
  • Vis forfatter(e) (2016). The effect of surgical and non-surgical weight loss on N-terminal pro-B-type natriuretic peptide and its relation to obstructive sleep apnea and pulmonary function. BMC Research Notes. 8 sider.
  • Vis forfatter(e) (2016). Oral appliance treatment in moderate and severe obstructive sleep apnoea patients non-adherent to CPAP. Journal of Oral Rehabilitation. 249-258.
  • Vis forfatter(e) (2016). Associations between obstructive lung disease and symptoms of obstructive sleep apnoea in a general population. Clinical Respiratory Journal. 31-39.
  • Vis forfatter(e) (2016). Airflow limitation as a risk factor for low bone mineral density and hip fracture. The Hordaland Health Study (HUSK) – 10 years follow-up of a general population. European Clinical Respiratory Journal. 8 sider.
  • Vis forfatter(e) (2016). Airflow limitation as a risk factor for low bone mineral density and hip fracture. European Clinical Respiratory Journal.
  • Vis forfatter(e) (2015). The Norwegian version of the Severe Respiratory Insufficiency Questionnaire. International Journal of Nursing Practice. 229-238.
  • Vis forfatter(e) (2015). Rosuvastatin treatment in stable chronic obstructive pulmonary disease (RODEO): a randomized controlled trial. Journal of Internal Medicine. 59-67.
  • Vis forfatter(e) (2015). Prevalence of excessive sleepiness is higher whereas insomnia is lower with greater severity of obstructive sleep apnea. Sleep and Breathing. 1387-1393.
  • Vis forfatter(e) (2014). Prevalence and correlates of insomnia and excessive sleepiness in adults with obstructive sleep apnea symptoms. Perceptual and Motor Skills. 571-586.
  • Vis forfatter(e) (2013). Electronic optional guidelines as a tool to improve the process of referring patients to specialized care: An intervention study. Scandinavian Journal of Primary Health Care. 166-171.
  • Vis forfatter(e) (2011). En kvinne med tilbakevendende arteriovenøse tromboser. Tidsskrift for Den norske legeforening. 1303-1306.
  • Vis forfatter(e) (2010). Prevalence and predictors of undiagnosed chronic obstructive pulmonary disease in a Norwegian adult general population. Clinical Respiratory Journal. 13-21.
  • Vis forfatter(e) (2008). Norwegian population surveys on respiratory health in adults: objectives, design, methods, quality controls and response rates. Clinical Respiratory Journal. 10-25.
  • Vis forfatter(e) (2008). Clinical data discriminating between adults with positive and negative results on bronchodilator testing. The International Journal of Tuberculosis and Lung Disease. 205-213.
  • Vis forfatter(e) (2007). Bronchodilator response to adrenergic (beta) (2)-agonists: Relationship to symptoms in an adult community. Respiratory Medicine. 1183-1190.
  • Vis forfatter(e) (2006). Post-bronchodilator spirometry reference values in adults and implications for disease management. American Journal of Respiratory and Critical Care Medicine. 1316-1325.
  • Vis forfatter(e) (2006). Nordic physician's management of asthma and chronic obstructive pulmonary disease. Respiratory Medicine. S31-S37.
  • Vis forfatter(e) (2006). Bronchodilator reversibility testing in an adult general population; the importance of smoking and anthropometrical variables on the response to a beta(2)-agonist. Pulmonary Pharmacology & Therapeutics. 272-280.
  • Vis forfatter(e) (2004). Factors determining performance of bronchodilator reversibility tests in middle-aged and elderly. Respiratory Medicine. 1071-1079.
Faglig foredrag
  • Vis forfatter(e) (2014). Søvnforstyrrelser.
Vitenskapelig foredrag
  • Vis forfatter(e) (2014). Effect Of Rosuvastatin Treatment In Stable COPD (RODEO) .
  • Vis forfatter(e) (2014). Oral appliance for sleep apnea. Tidsskrift for Den norske legeforening. 1030-1031.
  • Vis forfatter(e) (2007). Defining the lower limit of normal for FEV1/FVC - From the authors. American Journal of Respiratory and Critical Care Medicine. 101-102.
  • Vis forfatter(e) (2005). Behandling av obstruktiv søvnapné. Tidsskrift for Den norske legeforening. 199.
Populærvitenskapelig artikkel
  • Vis forfatter(e) (2018). Stor interesse for odontologisk søvnmedisin og søvnapné i Norge. Den norske tannlegeforenings tidende. 202-204.
  • Vis forfatter(e) (2022). Satsning på overvåkingsmedisin gjør oss bedre rustet. Dagens medisin.
  • Vis forfatter(e) (2022). Hva skjer med meg hvis jeg legges inn med covid-19 på Haukeland? . Bergens Tidende.
Brev til redaktøren
  • Vis forfatter(e) (2024). Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”. Journal of Allergy and Clinical Immunology: In Practice. 536-539.
  • Vis forfatter(e) (2008). Adrenergic bronchodilator test in community. Applicability and relationship to anthropometrical variables, smoking, respiratory symptoms, and lung function.
  • Vis forfatter(e) (2023). Søvnapnè: Virker umiddelbart.
  • Vis forfatter(e) (2013). Anxiety and depression in obstructive lung disease: A population-based observational study (The Hordaland Health Study(HUSK)).
  • Vis forfatter(e) (2012). Daytime respiratory symptoms are associated with obstructive sleep apnoea syndrome. Journal of Sleep Research. 229-230.
  • Vis forfatter(e) (2022). The prevalence of severe asthma, use of oral corticosteroid and management strategies in the Nordic countries: results from the pan-Nordic NORDSTAR cohort.
  • Vis forfatter(e) (2017). Health related quality of life in patients treated with long-term mechanical ventilation.
  • Vis forfatter(e) (2005). Strategy for selecting a spirometric reference population.
  • Vis forfatter(e) (2014). Skinnebehandling mot søvapne. Den norske tannlegeforenings tidende. 637-639.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) (2022). Cardiovascular remodeling in obstructive sleep apnea: focus on arterial stiffness, left ventricular geometry and atrial fibrillation. Expert Review of Cardiovascular Therapy. 455-464.
  • Vis forfatter(e) (2018). Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults. European Clinical Respiratory Journal. 1-20.
  • Vis forfatter(e) (2022). Alvorlig astma. Indremedisineren.
  • Vis forfatter(e) (2014). Skinnebehandling mot søvnapnè. Tidsskrift for Den norske legeforening. 1030-1031.

Se fullstendig oversikt over publikasjoner i CRIStin.